THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Javid Fazili to Hepatitis C

This is a "connection" page, showing publications Javid Fazili has written about Hepatitis C.
Connection Strength

0.325
  1. A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients. J Viral Hepat. 2013 Sep; 20(9):622-7.
    View in: PubMed
    Score: 0.104
  2. Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci. 2010 Feb; 339(2):169-73.
    View in: PubMed
    Score: 0.084
  3. A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone. Nat Clin Pract Gastroenterol Hepatol. 2009 Jan; 6(1):57-60.
    View in: PubMed
    Score: 0.077
  4. Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy. Am J Hematol. 2005 Mar; 78(3):212-5.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES